PfizerPFE

NYSE · USA · Segment 2 of 8 in the Medicine, pharma & life science value chain: Big pharma

Vaccines are what most people associate with Pfizer. The portfolio is considerably broader: oncology is a large part of it, and internal medicine covers much of the rest.

Big pharma: Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas.

Key metrics

Market cap

$152B

Price

$27.97

Today

−0.4%

Return YTD

+12.7%

Return 1Y

+9.1%

P/E

35.2

P/S

2.4

P/B

1.8

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

Big pharmaOncologyVaccines

In the value chain

Products & services

Vaccines
Oncology
Internal medicine

Competitors

Risks

Patent cliff
Declining covid revenue
Acquisition integration

Supply chain

Supplies →

Cardinal HealthCAH McKessonMCK CencoraCOR

← Suppliers

Thermo Fisher ScientificTMO West Pharmaceutical ServicesWST Charles River LaboratoriesCRL IQVIA HoldingsIQV Agilent TechnologiesA

Full supply chain for PFE →

Same segment: Big pharma

Johnson & JohnsonJNJ AbbVieABBV Merck & Co.MRK Bristol Myers SquibbBMY ZoetisZTS

Compare PFE

PFE vs JNJ PFE vs ABBV PFE vs MRK PFE vs BMY PFE vs ZTS

See where Pfizer sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →